Areas of Focus
- Glioma (Glioma Stem Cells, Tumor Microenvironment, Tumor Metabolism)
- Neurodegenerative Diseases (Parkinson's Disease)
- Neuroregulation Techniques (Deep Brain Stimulation, Spinal Cord Stimulation)
Work Experience
- 1999-2017 - Anhui Provincial Hospital, Anhui Institute of Stereotactic Neurosurgery - Deputy Chief Physician, Chief Physician
- 2017-present - Chief of Neurosurgery, The First Affiliated Hospital of USTC, Deputy Director of Anhui Institute of Stereotactic Neurosurgery
Academic Background & Achievements
- 1996-1999 Doctorate in Neurosurgery: Shanghai Second Medical University
- Leader in academic and technical fields in Anhui Province
- Recipient of the Chinese Medical Doctor Award
Publications
- CircSOBP suppresses the progression of glioma by disrupting glycolysis and promoting the MDA5-mediated immune response., Mu M, Niu W, Chu F, Dong Q, Hu S, Niu C., 2023
- MGCG regulates glioblastoma tumorigenicity via hnRNPK/ATG2A and promotes autophagy., Chu F, Wu P, Mu M, Hu S, Niu C., 2023
- Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12., Bao Z, Zhang N, Niu W, Mu M, Zhang X, Hu S, Niu C., 2022
- Exosomal circZNF800 Derived from Glioma Stem-like Cells Regulates Glioblastoma Tumorigenicity via the PIEZO1/Akt Axis., Zhang N, Wu P, Mu M, Niu C, Hu S., 2024
- Vascularization ability of glioma stem cells in different three-dimensional microenvironments., Wang X, Xu T, Niu C., 2023
Awards
- 2023: First Prize of Chinese Medical Science and Technology Award for research on neurosurgical minimally invasive treatment system based on domestic surgical robots
- 2018: Second Prize of Anhui Provincial Science and Technology Award for research and clinical application of key techniques in standardized surgical treatment of gliomas in functional brain areas
- 2020: Second Prize of Anhui Provincial Science and Technology Award for establishment and clinical application of precise surgical treatment system for cranial nerve diseases